Literature DB >> 6241750

Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.

J Fritschi, M Christe, B Lämmle, G A Marbet, W Berger, F Duckert.   

Abstract

We have studied 155 subjects, 48 normals, 36 diabetics without complications, 44 with complications and 27 patients with macroangiopathy. beta-Thromboglobulin (beta-TG) and platelet factor 4 (PF4) are elevated in the patients groups. There is no correlation between the plasma levels of beta-TG and the stages of either retinopathy or macroangiopathy or nephropathy. The difference is more marked between normals and diabetics with neuropathy (p = 0.026). The aggregation response to ADP and platelet activating factor (PAF) is enhanced at lower stimulator concentration. Using the beta-TG, PF4 and aggregation values the discriminant analysis allows a distinction of several subgroups especially with nephropathy and neuropathy (Table 6).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6241750

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Patterns of contact phase proteins indicating neuropathy in diabetic patients.

Authors:  P Meier; G A Marbet; W Berger; F Duckert; W Friedli
Journal:  Blut       Date:  1990-10

2.  Increased thromboplastic potential in diabetes: a multifactorial phenomenon.

Authors:  M M Landgraf-Leurs; T Ladik; B Smolka; T Bock; W Schramm; M Spannagl; R Landgraf
Journal:  Klin Wochenschr       Date:  1987-07-01

3.  Platelet hyper- and hypoaggregability in different microangiopathic complications of diabetes mellitus.

Authors:  P Szénási; L Tóth; L Romics; L Kammerer
Journal:  Acta Diabetol Lat       Date:  1988 Jan-Mar

4.  Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study.

Authors:  G Gamba; S B Solerte; G Grignani; L Pacchiarini; N Montani; E Ferrari
Journal:  Blut       Date:  1988-06

5.  Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.

Authors:  Nishank Jain; Fei Wan; Monica Kothari; Anuoluwapo Adelodun; Jerry Ware; Ravi Sarode; S Susan Hedayati
Journal:  BMC Nephrol       Date:  2019-10-29       Impact factor: 2.388

6.  Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity.

Authors:  Abu Saleh Md Moin; Ahmed Al-Qaissi; Thozhukat Sathyapalan; Stephen L Atkin; Alexandra E Butler
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-25       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.